Last reviewed · How we verify
Vitamin D chewable tablet supplementation
Vitamin D supplementation provides cholecalciferol (vitamin D3) to maintain adequate serum vitamin D levels, supporting calcium absorption and bone health.
Vitamin D supplementation provides cholecalciferol (vitamin D3) to maintain adequate serum vitamin D levels, supporting calcium absorption and bone health. Used for Vitamin D deficiency prevention and treatment, Support for bone health and calcium absorption.
At a glance
| Generic name | Vitamin D chewable tablet supplementation |
|---|---|
| Sponsor | CHU de Quebec-Universite Laval |
| Drug class | Vitamin supplement |
| Target | Vitamin D receptor (VDR) |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplementation / Bone health |
| Phase | FDA-approved |
Mechanism of action
Vitamin D is a fat-soluble vitamin that acts as a hormone precursor. After ingestion, it is converted in the liver to 25-hydroxyvitamin D and then in the kidneys to the active form 1,25-dihydroxyvitamin D, which regulates calcium and phosphate homeostasis, promotes intestinal calcium absorption, and supports immune function and bone mineralization.
Approved indications
- Vitamin D deficiency prevention and treatment
- Support for bone health and calcium absorption
Common side effects
- Hypercalcemia (with excessive supplementation)
- Nausea
- Constipation
- Headache
Key clinical trials
- A Comparative Dissolution and Absorption Study of an Orodispersible Powder, Chewable Tablet and Soft Gel Capsule Vitamin D3 Supplementation (NA)
- Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM) (NA)
- VItamiN D treatIng Chronic heArT Failure (the Effect of Vitamin D Supplementation in Patients With Heart Failure) (NA)
- Effect of Calcium and Vitamin D Supplementation With and Without Collagen Peptides in Postmenopausal Women With Osteopenia (NA)
- Comparison of Changes in Serum 25(OH)D Concentrations Following Vitamin D Supplementation With Chewable Tablets Versus Pills (PHASE4)
- Vitamin D and Severe Asthma Exacerbations (PHASE1)
- Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |